KeyBanc Capital Markets initiated coverage on Astrana Health
$ASTH
Professional Services
Consumer Discretionary
KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/12/2025 | $28.00 | Buy | Needham |
| 4/1/2025 | $36.00 | Equal Weight | Barclays |
| 10/14/2024 | $66.00 | Buy | TD Cowen |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 7/11/2024 | $44.00 → $50.00 | Hold → Buy | Truist |
| 5/30/2024 | $54.00 | Outperform | Robert W. Baird |
4 - Astrana Health, Inc. (0001083446) (Issuer)
4 - Astrana Health, Inc. (0001083446) (Issuer)
4 - Astrana Health, Inc. (0001083446) (Issuer)
8-K - Astrana Health, Inc. (0001083446) (Filer)
NT 10-K - Astrana Health, Inc. (0001083446) (Filer)
8-K - Astrana Health, Inc. (0001083446) (Filer)
ALHAMBRA, Calif., March 3, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences: The TD Cowen 45th Annual Health Care Conference, being held in Boston on Wednesday, March 4, 2026, including a fireside chat at 9:10am ET.The Jefferies Value-Based Healthca
Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m. ETReports total revenue for the year ended of $3,181.8 million, up 56% year-over-year, and at the higher end of guidanceReports adjusted EBITDA for the year ended of $205.4 million and free cash flow(1) of $104.5 millionALHAMBRA, Calif., March 2, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading physician-centric, technology-powered, risk-bearing healthcare management company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial result
ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the open of the stock market on Monday, March 2, 2026. The Company will discuss those results on a conference call at 5:30 a.m. PT/8:30 a.m. ET that same day.
Needham initiated coverage of Astrana Health with a rating of Buy and set a new price target of $28.00
Barclays initiated coverage of Astrana Health with a rating of Equal Weight and set a new price target of $36.00
TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00
Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m. ETReports total revenue for the year ended of $3,181.8 million, up 56% year-over-year, and at the higher end of guidanceReports adjusted EBITDA for the year ended of $205.4 million and free cash flow(1) of $104.5 millionALHAMBRA, Calif., March 2, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading physician-centric, technology-powered, risk-bearing healthcare management company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial result
ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the open of the stock market on Monday, March 2, 2026. The Company will discuss those results on a conference call at 5:30 a.m. PT/8:30 a.m. ET that same day.
Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $956.0 million, up 100% year-over-year, and at the higher end of guidanceReports adjusted EBITDA of $68.5 million, at the higher end of guidanceCloses Prospect Health acquisition where standalone third quarter performance exceeded expectationsContinuing to control medical costs well; reiterating full-year trend expectationsUpdates full-year 2025 guidance to account for full-risk contract delays unrelated to core performanceALHAMBRA, Calif., Nov. 6, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (